Clinical Trials Logo

Thrombophilia clinical trials

View clinical trials related to Thrombophilia.

Filter by:

NCT ID: NCT01547728 Terminated - Clinical trials for Thrombophilia Due to Acquired Antithrombin III Deficiency

Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery

Start date: February 2012
Phase: Phase 4
Study type: Interventional

The objective of this study is to prospectively evaluate the response of recombinant antithrombin (rAT) (ATRYN) in patients who are heparin resistant and are scheduled to undergo cardiac surgery.

NCT ID: NCT01487291 Completed - Insulin Resistance Clinical Trials

Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Psychotic Patients

Start date: January 2013
Phase: N/A
Study type: Observational

At the Thrombophilia Clinic of the Hospital Federal dos Servidores do Estado do Rio de Janeiro there is a high prevalence of acute psychotic episodes, which allows the investigators to raise the suspicion that the thrombotic tendency or hypofibrinolysis play a role in the onset of the disease. It is striking that most of these patients, after some time on anticoagulants, no longer need to take psychiatric medication.

NCT ID: NCT01486511 Unknown status - Pulmonary Embolism Clinical Trials

Pulmonary Embolism After Liver Resection

Start date: January 2007
Phase: N/A
Study type: Observational

Major surgery is associated with a postoperative hypercoagulable state related to the surgical trauma that may lead to thromboembolic complications. To the investigators knowledge, only two series have reported the risk of PE after liver surgery with an incidence of up to 6.3% The purpose of this study is to identify the independent risk factors associated with the development of PE after elective liver surgery.

NCT ID: NCT01475149 Completed - Clinical trials for Systemic Lupus Erythematosus

Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)

Start date: September 2010
Phase: N/A
Study type: Observational

This 12 week study will observe patients with and without systemic lupus erythematosus who have persistent antiphospholipid antibodies in the blood who are starting a medicine called hydroxychloroquine. It will measure if these patients have a change in a blood test called the annexin A5 resistance assay over that 12 week period.

NCT ID: NCT01416454 Completed - Thrombophilia Clinical Trials

Thromboelastography to Assess Age-Related Coagulation Differences in Patients Undergoing Cesarean Delivery

Start date: October 2010
Phase: N/A
Study type: Observational

The purpose of the study is to assess potential age-related differences on coagulation profile of patients undergoing Cesarean Section, using thromboelastography (TEG). The investigators will compare coagulation data collected from the study to assess potential differences in coagulation parameters for the following age groups: (i) women less than 35 yrs (ii) women 35 yrs or older.

NCT ID: NCT01372553 Completed - Breast Cancer Clinical Trials

Guilford Genomic Medicine Initiative (GGMI)

GGMI
Start date: October 2009
Phase: Phase 4
Study type: Observational

- Genomic medicine, using genetic information to improve health outcomes, is heralded as the answer to rising medical costs by focusing on prevention and tailored care. Despite its potential, little investigation has focused on how genomic medicine can be applied in health care. To be effective, it requires new ways to learn, deliver, and communicate medical information. It will also raise new ethical questions. - The overall goal of Guilford Genomic Medicine Initiative (GGMI) is to identify the specific challenges in "re-structuring" an existing medical system to integrate genomic medicine, and create solutions that can be used by other medical systems, such as the extensive military medical care system. To accomplish this goal, GGMI includes the development of a large-scale genomic medicine education initiative targeted at the community, providers, and patients, and a clinical systems model to implement strategies to facilitate the integration of genomic medicine into several pilot practices.

NCT ID: NCT01214772 Completed - Pregnancy Clinical Trials

The Effect of Heparin in Treatment IVF-ET Failure

Start date: May 2009
Phase: Phase 4
Study type: Interventional

Embryo transfer failure is defined as ≥3 IVF-embryo transfer failures without pregnancy . In spite of transfer of 3 good quality embryos , just 20-30% of women undergoing IVF will achieve ongoing pregnancy . There are multiple factors that influence IVF-failure. Autoantibodies may be one of the possible causes of IVF-failure , especially in unexplained and mechanical infertility . In some studies , antiphospholipid antibody is considered as causative factor on implantation and embryo failure. However some investigators showed that combination therapy with heparin/aspirin in women with positive antiphospholipid antibody is not effective in improving of IVF-outcome . In prospective studies were not confirmed association between antiphospholipid antibody abnormalities and IVF-failure. Recently has been relationship between thrombophilia and IVF and implantation failure. The effect of unfractionated heparin in assisted reproductive technology (ART) cycles is prevention of thrombosis in implantation site . Although its effect is not restricted to anticoagulation and also can modulate apposition , adhesion , and penetration of embryo . Other advantages are decreasing thrombophilic risk in COH ( controlled ovarian hyperstimulation) cycles with administration of gonadotrophins . So heparin make better pregnancy rate in repeated IVF-ET failures. There are few studies in regard to heparin effects on IVF cycles outcome . The purpose of this study is evaluation of unfractionated heparin effects on improvement of ART outcome . This study was a prospective randomized controlled trial to assess whether administration of heparin would increased pregnancy rates in women with repeated ET-IVF failures.

NCT ID: NCT01160159 Recruiting - Thrombophilia Clinical Trials

Arterial Microcirculation, Macrocirculation and Thrombophilias

MICMAC
Start date: March 2010
Phase: N/A
Study type: Observational

Rationale: To analyse the arterial state of women with thrombophilia by techniques studying micro and arterial macrocirculation because of a reported and still discussed increase risk in cardio-vascular events in these women. Primary objective: To measure endothelium dependent vasodilatation (VDE) in controls and in women with thrombophilia.

NCT ID: NCT01046942 Recruiting - Thrombosis Clinical Trials

ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery

TEG-CABG
Start date: November 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether adding clopidogrel to aspirin after coronary bypass operation (CABG) improves graft patency, in patients that have preoperatively increased platelet activity(hypercoagulable) and therefore greater risk of graft occlusion( thrombosis).

NCT ID: NCT01019655 Not yet recruiting - Clinical trials for Pregnancy and Thrombophilia

Heparin for Pregnant Women With Thrombophilia

Start date: January 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate whether heparin is an effective treatment in pregnant women at risk for thrombosis and other pregnancy-associated complications.